Effect of zoledronic acid on disseminated tumour cells in women with locally advanced breast cancer: an open label, randomised, phase 2 trial
Rebecca Aft(Washington University in St. Louis), Michael Naughton(Washington University in St. Louis), Kathryn Trinkaus(Washington University in St. Louis), Mark A. Watson(Washington University in St. Louis), Lourdes R. Ylagan(Washington University in St. Louis), Mariana Chávez‐MacGregor(The University of Texas MD Anderson Cancer Center), Jing Zhai(Washington University in St. Louis), S. H. Kuo(Washington University in St. Louis), William D. Shannon(Washington University in St. Louis), K Diemer(Washington University in St. Louis), Virginia M. Herrmann(Medical University of South Carolina), Jill R. Dietz(Washington University in St. Louis), Amjad Ali(Washington University in St. Louis), Matthew J. Ellis(Washington University in St. Louis), Peter Weiss(Washington University in St. Louis), Timothy J. Eberlein(Washington University in St. Louis), X. Cynthia(Washington University in St. Louis), Paula M. Fracasso(University of Virginia), Imran Zoberi(Washington University in St. Louis), Marie E. Taylor(Washington University in St. Louis), William E. Gillanders(Washington University in St. Louis), Timothy Pluard(Washington University in St. Louis), Joanne Mortimer(City of Hope), Katherine N. Weilbaecher(Washington University in St. Louis)
Cited by 273Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis